Harlan Waksal Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Harlan Waksal.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Harlan Waksal. Harlan Waksal is Director in Sevion Therapeutics, Inc. ($SVON) and President, CEO in Kadmon Holdings, Inc. ($KDMN).
Latest Insider Trading Transactions of Harlan Waksal
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 06 2021 | KDMN | Kadmon Holdings, I ... | Waksal Harlan | President, CEO | Option Exercise | A | 4.06 | 327,498 | 1,329,642 | 982,500 | |
| Jan 12 2021 | KDMN | Kadmon Holdings, I ... | Waksal Harlan | President, CEO | Option Exercise | A | 3.96 | 2,000,000 | 7,920,000 | 2,000,000 | |
| Sep 10 2020 | KDMN | Kadmon Holdings, I ... | Waksal Harlan | President, CEO | Option Exercise | A | 4.06 | 109,167 | 443,218 | 655,002 | |
| Mar 16 2020 | KDMN | Kadmon Holdings, I ... | Waksal Harlan | President, CEO | Buy | P | 2.93 | 16,000 | 46,811 | 152,945 | 136.9 K to 152.9 K (+11.68 %) |
| Mar 11 2020 | KDMN | Kadmon Holdings, I ... | Waksal Harlan | President, CEO | Buy | P | 3.96 | 12,600 | 49,859 | 136,945 | 124.3 K to 136.9 K (+10.13 %) |
| Mar 11 2020 | KDMN | Kadmon Holdings, I ... | Waksal Harlan | President, CEO | Grant | A | 2.25 | 7,716 | 17,361 | 124,345 | 116.6 K to 124.3 K (+6.62 %) |
| Mar 11 2020 | KDMN | Kadmon Holdings, I ... | Waksal Harlan | President, CEO | Grant | A | 2.84 | 5,882 | 16,705 | 116,629 | 110.7 K to 116.6 K (+5.31 %) |
| Nov 19 2019 | KDMN | Kadmon Holdings, I ... | Waksal Harlan | President, CEO | Option Exercise | A | 4.14 | 1,350,000 | 5,589,000 | 1,350,000 | |
| Oct 24 2019 | KDMN | Kadmon Holdings, I ... | Waksal Harlan | President, CEO | Option Exercise | A | 4.06 | 109,167 | 443,218 | 545,835 | |
| Sep 10 2019 | KDMN | Kadmon Holdings, I ... | Waksal Harlan | President, CEO | Option Exercise | A | 4.06 | 109,167 | 443,218 | 436,668 | |
| Jun 14 2019 | KDMN | Kadmon Holdings, I ... | Waksal Harlan | President, CEO | Option Exercise | A | 4.06 | 109,167 | 443,218 | 327,501 | |
| Apr 05 2019 | KDMN | Kadmon Holdings, I ... | Waksal Harlan | President, CEO | Option Exercise | A | 4.06 | 218,334 | 886,436 | 218,334 | |
| Dec 12 2017 | KDMN | Kadmon Holdings, I ... | Waksal Harlan | President, CEO | Option Exercise | A | 3.64 | 655,000 | 2,384,200 | 655,000 | |
| Aug 10 2017 | KDMN | Kadmon Holdings, I ... | Waksal Harlan | President, CEO | Buy | P | 2.27 | 5,000 | 11,333 | 110,747 | 105.7 K to 110.7 K (+4.73 %) |
| Aug 08 2017 | KDMN | Kadmon Holdings, I ... | Waksal Harlan | President, CEO | Buy | P | 2.34 | 3,707 | 8,667 | 105,747 | 102 K to 105.7 K (+3.63 %) |
| Nov 16 2016 | KDMN | Kadmon Holdings, I ... | Waksal Harlan | President, CEO | Buy | P | 6.37 | 2,000 | 12,733 | 102,040 | 100 K to 102 K (+2.00 %) |
| Nov 14 2016 | KDMN | Kadmon Holdings, I ... | Waksal Harlan | President, CEO | Buy | P | 6.79 | 2,000 | 13,580 | 100,040 | 98 K to 100 K (+2.04 %) |
| Nov 23 2015 | SVON | Sevion Therapeutic ... | Waksal Harlan | Director | Option Exercise | A | 0.50 | 40,000 | 20,000 | 40,000 | |
| May 20 2015 | SVON | Sevion Therapeutic ... | Waksal Harlan | Director | Option Exercise | A | 0.97 | 11,340 | 11,000 | 147,693 | |
| Feb 23 2015 | SVON | Sevion Therapeutic ... | Waksal Harlan | Director | Option Exercise | A | 0.54 | 26,552 | 14,338 | 136,353 | |
| May 19 2011 | SVON | Sevion Therapeutic ... | Waksal Harlan | Director | Option Exercise | A | 0.27 | 51,852 | 14,000 | 1,157,654 | |
| Feb 16 2011 | SVON | Sevion Therapeutic ... | Waksal Harlan | Director | Option Exercise | A | 0.29 | 45,690 | 13,250 | 1,105,802 | |
| Nov 19 2010 | SVON | Sevion Therapeutic ... | Waksal Harlan | Director | Option Exercise | A | 0.26 | 500,000 | 130,000 | 1,060,112 | |
| Nov 19 2010 | SVON | Sevion Therapeutic ... | Waksal Harlan | Director | Option Exercise | A | 0.26 | 200,000 | 52,000 | 560,112 | |
| Nov 19 2010 | SVON | Sevion Therapeutic ... | Waksal Harlan | Director | Option Exercise | A | 0.26 | 96,154 | 25,000 | 360,112 | |
| Jun 03 2010 | SVON | Sevion Therapeutic ... | Waksal Harlan | Director | Option Exercise | P | 0.32 | 200 | 64 | 200 | |
| Jun 03 2010 | SVON | Sevion Therapeutic ... | Waksal Harlan | Director | Option Exercise | P | 0.35 | 625,000 | 218,750 | 1,167,333 | |
| May 27 2010 | SVON | Sevion Therapeutic ... | Waksal Harlan | Director | Buy | C | 0.83 | 631,176 | 523,876 | 822,168 | 191 K to 822.2 K (+330.47 %) |
| May 27 2010 | SVON | Sevion Therapeutic ... | Waksal Harlan | Director | Grant | A | 0.51 | 12,078 | 6,202 | 190,992 | 178.9 K to 191 K (+6.75 %) |
| May 27 2010 | SVON | Sevion Therapeutic ... | Waksal Harlan | Director | Grant | A | 0.37 | 28,135 | 10,334 | 178,914 | 150.8 K to 178.9 K (+18.66 %) |
| May 24 2010 | SVON | Sevion Therapeutic ... | Waksal Harlan | Director | Option Exercise | A | 0.61 | 22,951 | 14,000 | 263,958 | |
| Feb 23 2010 | SVON | Sevion Therapeutic ... | Waksal Harlan | Director | Option Exercise | P | 0.83 | 87,313 | 72,470 | 542,333 | |
| Feb 23 2010 | SVON | Sevion Therapeutic ... | Waksal Harlan | Director | Option Exercise | P | 0.83 | 130,969 | 108,704 | 455,020 | |
| Feb 23 2010 | SVON | Sevion Therapeutic ... | Waksal Harlan | Director | Option Exercise | P | 1.01 | 87,313 | 88,186 | 324,051 | |
| Feb 23 2010 | SVON | Sevion Therapeutic ... | Waksal Harlan | Director | Option Exercise | P | 1.01 | 130,969 | 132,279 | 236,738 | |
| Feb 23 2010 | SVON | Sevion Therapeutic ... | Waksal Harlan | Director | Option Exercise | P | 1.01 | 78,581 | 79,367 | 105,769 | |
| Feb 23 2010 | SVON | Sevion Therapeutic ... | Waksal Harlan | Director | Buy | P | 0.00 | 135,779 | 0 | 150,779 | 15 K to 150.8 K (+905.19 %) |
| Feb 23 2010 | SVON | Sevion Therapeutic ... | Waksal Harlan | Director | Option Exercise | A | 0.29 | 77,500 | 22,475 | 241,007 | |
| Nov 23 2009 | SVON | Sevion Therapeutic ... | Waksal Harlan | Director | Option Exercise | A | 0.39 | 70,000 | 27,300 | 163,507 | |
| Nov 23 2009 | SVON | Sevion Therapeutic ... | Waksal Harlan | Director | Option Exercise | A | 0.39 | 66,923 | 26,100 | 93,507 | |
| Nov 23 2009 | SVON | Sevion Therapeutic ... | Waksal Harlan | Director | Option Exercise | A | 0.59 | 19,492 | 11,500 | 26,584 | |
| Jul 31 2009 | SVON | Sevion Therapeutic ... | Waksal Harlan | Director | Buy | P | 0.00 | 13,688 | 0 | 27,188 | 13.5 K to 27.2 K (+101.39 %) |
| Jul 31 2009 | SVON | Sevion Therapeutic ... | Waksal Harlan | Director | Buy | P | 0.00 | 13,500 | 0 | 13,500 | 0 to 13.5 K |
| Jul 31 2009 | SVON | Sevion Therapeutic ... | Waksal Harlan | Director | Buy | P | 0.90 | 15,000 | 13,500 | 15,000 | 0 to 15 K |
| Feb 24 2009 | SVON | Sevion Therapeutic ... | Waksal Harlan | Director | Option Exercise | A | 0.47 | 7,092 | 3,333 | 7,092 |
Page: 1